ArticleOral oncology2016

A pilot study of cetuximab and the hedgehog inhibitor IPI-926 in recurrent/metastatic head and neck squamous cell carcinoma.

Daniel W Bowles et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.